Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 431, 493 (30 September 2004) | doi:10.1038/431493a; Published online 29 September 2004
Global AIDS trial denied patients as US balks at generic drug use
Erika Check
US opposition to generic AIDS drugs is unnecessarily delaying the progress of a major international clinical trial, critics say.The $120-million trial, which is known as Strategies for Management of Anti-Retroviral Therapy, or SMART, is sponsored by the US National Institute of Allergy and Infectious Diseases (NIAID).
To read this story in full you will need to login or make a payment (see right).